Last 12 months
Inside the activity.
1 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2020 Filed Jun 23, 2020 20:27 UTC |
Broadfoot Jill MarieChief Financial Officer
|
PurchaseCommon Stock | 1,850 | $4.22 | $7,807.00 |
DisclosureSEC source: 0001209191-20-038468 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,153 F1 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $4.21 to $4.24 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 26, 2020 Filed May 28, 2020 20:17 UTC |
Shukla SanjayPresident and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $4.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032780 · doc4.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2030-05-26 F1 · derivative.exercise_date: 50% of the shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 26, 2020, such that these shares will be fully exercisable on May 26, 2024; 25% of the shares subject to this option will vest on May 26, 2021 if and only if a clinical development milestone is achieved by September 30, 2020; and the remaining 25% of the shares will vest on May 26, 2021 if and only if an additional clinical development milestone is achieved by September 30, 2020. Read SEC document |
| May 26, 2020 Filed May 29, 2020 00:22 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032784 · doc4.xml · derivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-05-26 F2 · derivative.exercise_date: 50% of the shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 26, 2020, such that these shares will be fully exercisable on May 26, 2024; 25% of the shares subject to this option will vest on May 26, 2021 if and only if a clinical development milestone is achieved by September 30, 2020; and the remaining 25% of the shares will vest on May 26, 2021 if and only if an additional clinical development milestone is achieved by September 30, 2020. Read SEC document |
| May 26, 2020 Filed May 29, 2020 00:26 UTC |
DENYES NANCYGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032794 · doc4.xml · derivative · entry 3 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-05-26 F4 · derivative.exercise_date: 50% of the shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 26, 2020, such that these shares will be fully exercisable on May 26, 2024; 25% of the shares subject to this option will vest on May 26, 2021 if and only if a clinical development milestone is achieved by September 30, 2020; and the remaining 25% of the shares will vest on May 26, 2021 if and only if an additional clinical development milestone is achieved by September 30, 2020. Read SEC document |
| May 26, 2020 Filed Mar 9, 2021 16:23 UTC Amendment |
Shukla SanjayDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 73,142 | $0.00 Strike: $4.06 | $0.00 |
DisclosureSEC source: 0001209191-21-018977 · doc4a.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,142 Underlying: Common Stock · 73,142 shares Expires 2030-05-26 F1 · shares: The option grant was originally intended for 80,000 shares. However, that size of grant was in excess of an annual grant limit in the Issuer's equity plan and, as a result, the portion of the award that was in excess of the plan limit was disgorged. F2 · derivative.exercise_date: 50% of the shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 26, 2020, such that these shares will be fully exercisable on May 26, 2024; 25% of the shares subject to this option will vest on May 26, 2021 if and only if a clinical development milestone is achieved by September 30, 2020; and the remaining 25% of the shares will vest on May 26, 2021 if and only if an additional clinical development milestone is achieved by September 30, 2020. Read SEC document |
| May 20, 2020 Filed May 23, 2020 00:13 UTC |
SCHIMMEL PAULDirector
|
SaleCommon Stock | 8,447 | $3.64 | $30,738.63 |
DisclosureSEC source: 0001209191-20-031886 · doc4.xml · nonDerivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 429,143 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.605 to $3.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: There shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000. Read SEC document |
| May 20, 2020 Filed May 29, 2020 00:26 UTC |
DENYES NANCYGeneral Counsel
|
SaleCommon Stock | 322 | $3.62 | $1,165.64 |
DisclosureSEC source: 0001209191-20-032794 · doc4.xml · nonDerivative · entry 2 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,735 F3 · kind: Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on May 16, 2018. F3 · shares: Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on May 16, 2018. Read SEC document |
| May 16, 2020 Filed May 29, 2020 00:26 UTC |
DENYES NANCYGeneral Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 892 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032794 · doc4.xml · derivative · entry 4 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 892 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units (RSU) convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on May 16, 2019. F5 · derivative.expiration_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on May 16, 2019. Read SEC document |
| May 16, 2020 Filed May 29, 2020 00:26 UTC |
DENYES NANCYGeneral Counsel
|
Exercise / conversionCommon Stock | 892 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-032794 · doc4.xml · nonDerivative · entry 1 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units (RSU) convert into common stock on a one-for-one basis. F2 · balance_after: Includes 178 shares acquired under the Company's 2015 Employee Stock Purchase Plan (ESPP) on May 15, 2020. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:57 UTC |
Gross Jane ADirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001209191-20-027966 · doc4.xml · derivative · entry 1 Gross Jane A · CIK 0001684258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2030-05-06 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 06, 2020 Filed May 8, 2020 21:14 UTC |
SCHIMMEL PAULDirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001209191-20-027995 · doc4.xml · derivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2030-05-06 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 06, 2020 Filed May 8, 2020 16:48 UTC |
CLARKE JOHN KDirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001209191-20-027949 · doc4.xml · derivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2030-05-06 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 06, 2020 Filed May 8, 2020 21:08 UTC |
Lucas SvetlanaDirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001209191-20-027984 · doc4.xml · derivative · entry 1 Lucas Svetlana · CIK 0001781292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2030-05-06 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 06, 2020 Filed May 8, 2020 21:02 UTC |
Hatfield Jeffrey S.Director
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001209191-20-027974 · doc4.xml · derivative · entry 1 Hatfield Jeffrey S. · CIK 0001609879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2030-05-06 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:53 UTC |
Coughlin TimothyDirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $3.65 | $0.00 |
DisclosureSEC source: 0001209191-20-027960 · doc4.xml · derivative · entry 1 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2030-05-06 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| February 10, 2020 Filed Feb 11, 2020 16:58 UTC |
SCHIMMEL PAULDirector
|
PurchaseCommon Stock | 254,000 | $4.25 | $1,079,500.00 |
DisclosureSEC source: 0001209191-20-008205 · doc4.xml · nonDerivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 437,590 F1 · shares: Represents shares purchased in an underwritten public offering at a public offering price of $4.25 per share. F1 · price: Represents shares purchased in an underwritten public offering at a public offering price of $4.25 per share. F2 · ownership.nature: There shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000. Read SEC document |
| February 07, 2020 Filed Feb 7, 2020 19:37 UTC |
Shukla SanjayPresident and CEO
|
SaleCommon stock | 745 | $4.03 | $3,002.35 |
DisclosureSEC source: 0001209191-20-007719 · doc4.xml · nonDerivative · entry 2 Shukla Sanjay · CIK 0001671026 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,291 F3 · kind: Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 6, 2019. Read SEC document |
| February 07, 2020 Filed Feb 8, 2020 00:30 UTC |
Broadfoot Jill MarieChief Financial Officer
|
SaleCommon stock | 375 | $4.03 | $1,511.25 |
DisclosureSEC source: 0001209191-20-007710 · doc4.xml · nonDerivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,125 F4 · kind: Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 6, 2019. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 19:37 UTC |
Shukla SanjayPresident and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007719 · doc4.xml · derivative · entry 4 Shukla Sanjay · CIK 0001671026 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,786 Underlying: Common Stock · 1,786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 6, 2019. F5 · derivative.exercise_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020. F5 · derivative.expiration_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 19:37 UTC |
Shukla SanjayPresident and CEO
|
Exercise / conversionCommon stock | 1,786 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-007719 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 6, 2019. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 06, 2020 Filed Feb 8, 2020 00:30 UTC |
Broadfoot Jill MarieChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 893 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007710 · doc4.xml · derivative · entry 4 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 893 Underlying: Common Stock · 893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020. F6 · derivative.expiration_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020. Read SEC document |
| February 06, 2020 Filed Feb 8, 2020 00:30 UTC |
Broadfoot Jill MarieChief Financial Officer
|
Exercise / conversionCommon stock | 893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-007710 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 6, 2019. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. F3 · balance_after: Includes 718 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 16, 2019. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 19:37 UTC |
Shukla SanjayPresident and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 39,327 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001209191-20-007719 · doc4.xml · derivative · entry 3 Shukla Sanjay · CIK 0001671026 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,327 Underlying: Common Stock · 39,327 shares Expires 2030-02-05 F4 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 5, 2020, such that this option will be fully exercisable on February 5, 2024. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 05, 2020 Filed Feb 8, 2020 00:30 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,359 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001209191-20-007710 · doc4.xml · derivative · entry 3 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,359 Underlying: Common Stock · 23,359 shares Expires 2030-02-05 F5 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 5, 2020, such that this option will be fully exercisable on February 5, 2024. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 05, 2020 Filed Feb 8, 2020 00:34 UTC |
DENYES NANCYGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 13,778 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001209191-20-007716 · doc4.xml · derivative · entry 1 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,778 Underlying: Common Stock · 13,778 shares Expires 2030-02-05 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 5, 2020, such that this option will be fully exercisable on February 5, 2024. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:14 UTC |
Gross Jane ADirector
|
GrantStock Option (right to buy) · Derivative | 2,285 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001209191-19-040447 · doc4.xml · derivative · entry 1 Gross Jane A · CIK 0001684258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,285 Underlying: Common Stock · 2,285 shares Expires 2029-06-28 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning July 28, 2019, such that this option will be fully exercisable on June 28, 2022, subject to the recipient's continued service on the Issuer's Board of Directors. F2 · derivative.underlying_shares: The shares of Common Stock reported herein give effect to the 1-for-14 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Restated Certificate of Incorporation filed with the Secretary of State of Delaware on June 28, 2019. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 21:16 UTC |
Lucas SvetlanaDirector
|
GrantStock Option (right to buy) · Derivative | 2,285 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001209191-19-040458 · doc4.xml · derivative · entry 1 Lucas Svetlana · CIK 0001781292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,285 Underlying: Common Stock · 2,285 shares Expires 2029-06-28 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning July 28, 2019, such that this option will be fully exercisable on June 28, 2022, subject to the recipient's continued service on the Issuer's Board of Directors. F2 · derivative.underlying_shares: The shares of Common Stock reported herein give effect to the 1-for-14 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Restated Certificate of Incorporation filed with the Secretary of State of Delaware on June 28, 2019. Read SEC document |
| May 17, 2019 Filed May 20, 2019 20:38 UTC |
DENYES NANCYGeneral Counsel
|
SaleCommon Stock | 4,651 | $0.45 | $2,093.42 |
DisclosureSEC source: 0001209191-19-031424 · doc4.xml · nonDerivative · entry 2 Krueger Nancy · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,348 F3 · kind: Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on May 16, 2018. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:38 UTC |
DENYES NANCYGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031424 · doc4.xml · derivative · entry 3 Krueger Nancy · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on May 16, 2018. F4 · derivative.exercise_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on May 16, 2019. F4 · derivative.expiration_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on May 16, 2019. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:38 UTC |
DENYES NANCYGeneral Counsel
|
Exercise / conversionCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031424 · doc4.xml · nonDerivative · entry 1 Krueger Nancy · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on May 16, 2018. F2 · balance_after: Includes 2,500 shares acquired under the Company's 2015 Employee Stock Purchase Plan (ESPP) on May 15, 2019. Read SEC document |
| May 08, 2019 Filed May 10, 2019 19:40 UTC |
BLAIR JAMES CDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0000904454-19-000386 · edgar.xml · derivative · entry 1 BLAIR JAMES C · CIK 0001024000 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-08 F1 · derivative.exercise_date: The option vests in full on the earlier of the one-year anniversary of the date of grant or the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 08, 2019 Filed May 10, 2019 17:01 UTC |
CLARKE JOHN KDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001209191-19-029005 · doc4.xml · derivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-08 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 8, 2020 or (ii) the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 08, 2019 Filed May 10, 2019 17:29 UTC |
MENDLEIN JOHNDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001209191-19-029044 · doc4.xml · derivative · entry 1 MENDLEIN JOHN · CIK 0001238362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-08 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 8, 2020 or (ii) the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 08, 2019 Filed May 10, 2019 21:35 UTC |
SCHIMMEL PAULDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001209191-19-029051 · doc4.xml · derivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-08 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 8, 2020 or (ii) the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 08, 2019 Filed May 10, 2019 21:22 UTC |
Hatfield Jeffrey S.Director
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001209191-19-029039 · doc4.xml · derivative · entry 1 Hatfield Jeffrey S. · CIK 0001609879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-08 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 8, 2020 or (ii) the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| May 08, 2019 Filed May 10, 2019 21:06 UTC |
Coughlin TimothyDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001209191-19-029011 · doc4.xml · derivative · entry 1 Coughlin Timothy P · CIK 0001376043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-08 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 8, 2020 or (ii) the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 20:31 UTC |
SCHIMMEL PAULDirector
|
GrantCommon Stock | 1,848,428 | $0.54 | $999,999.55 |
DisclosureSEC source: 0001209191-19-024764 · doc4.xml · nonDerivative · entry 3 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,570,242 F2 · shares: Represents shares acquired in a registered direct offering pursuant to a Securities Purchase Agreement, dated April 10, 2019, entered between aTyr Pharma, Inc. and the investors named therein. Pursuant to the terms of the Securities Purchase Agreement, investors purchased shares of common stock at a purchase price of $0.541 per share. F2 · price: Represents shares acquired in a registered direct offering pursuant to a Securities Purchase Agreement, dated April 10, 2019, entered between aTyr Pharma, Inc. and the investors named therein. Pursuant to the terms of the Securities Purchase Agreement, investors purchased shares of common stock at a purchase price of $0.541 per share. F3 · ownership.nature: These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 19:09 UTC |
Shukla SanjayPresident and CEO
|
GrantRestricted Stock Unit · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-008750 · doc4.xml · derivative · entry 2 Shukla Sanjay · CIK 0001671026 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs are scheduled to vest in two equal annual installments beginning on February 6, 2020, such that the RSUs will fully vest on February 6, 2021. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F3 · derivative.expiration_date: The RSUs are scheduled to vest in two equal annual installments beginning on February 6, 2020, such that the RSUs will fully vest on February 6, 2021. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 19:09 UTC |
Shukla SanjayPresident and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001209191-19-008750 · doc4.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-02-06 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2019, such that this option will be fully exercisable on February 6, 2023. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 06, 2019 Filed Feb 9, 2019 00:16 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-008757 · doc4.xml · derivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs are scheduled to vest in two equal annual installments beginning on February 6, 2020, such that the RSUs will fully vest on February 6, 2021. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F3 · derivative.expiration_date: The RSUs are scheduled to vest in two equal annual installments beginning on February 6, 2020, such that the RSUs will fully vest on February 6, 2021. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 06, 2019 Filed Feb 9, 2019 00:16 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001209191-19-008757 · doc4.xml · derivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-02-06 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2019, such that this option will be fully exercisable on February 6, 2023. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 06, 2019 Filed Feb 9, 2019 01:12 UTC |
DENYES NANCYGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001209191-19-008781 · doc4.xml · derivative · entry 1 Krueger Nancy · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2029-02-06 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2019, such that this option will be fully exercisable on February 6, 2023. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| December 21, 2018 Filed Dec 26, 2018 16:15 UTC |
MENDLEIN JOHNDirector
|
PurchaseCommon Stock | 195,000 | $0.42 | $82,602.00 |
DisclosureSEC source: 0001209191-18-064090 · doc4.xml · nonDerivative · entry 2 MENDLEIN JOHN · CIK 0001238362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 615,382 F2 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $0.4048 to $0.4300 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 20, 2018 Filed Dec 26, 2018 16:15 UTC |
MENDLEIN JOHNDirector
|
PurchaseCommon Stock | 50,000 | $0.41 | $20,645.00 |
DisclosureSEC source: 0001209191-18-064090 · doc4.xml · nonDerivative · entry 1 MENDLEIN JOHN · CIK 0001238362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,382 F1 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $0.4013 to $0.4100 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:12 UTC |
SCHIMMEL PAULDirector
|
PurchaseCommon Stock | 147,225 | $0.54 | $79,795.95 |
DisclosureSEC source: 0001209191-18-060168 · doc4.xml · nonDerivative · entry 2 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 882,302 F1 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $0.5404 to $0.5422 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 20:38 UTC |
Broadfoot Jill MarieChief Financial Officer
|
PurchaseCommon Stock | 38,000 | $0.84 | $31,737.60 |
DisclosureSEC source: 0001209191-18-051897 · doc4.xml · nonDerivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F2 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $0.8229 to $0.8480 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 20:38 UTC |
Broadfoot Jill MarieChief Financial Officer
|
PurchaseCommon Stock | 26,000 | $0.81 | $21,117.20 |
DisclosureSEC source: 0001209191-18-051897 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 F1 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $0.7989 to $0.8184 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:12 UTC |
Broadfoot Jill MarieChief Financial Officer
|
PurchaseCommon Stock | 26,000 | $0.73 | $19,055.40 |
DisclosureSEC source: 0001209191-18-051547 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $0.729 to $0.736 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 20:04 UTC |
SCHIMMEL PAULDirector
|
PurchaseCommon Stock | 20,749 | $0.76 | $15,709.07 |
DisclosureSEC source: 0001209191-18-049509 · doc4.xml · nonDerivative · entry 3 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 735,077 F3 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $0.7488 to $0.76 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. Read SEC document |
| August 31, 2018 Filed Sep 5, 2018 20:04 UTC |
SCHIMMEL PAULDirector
|
PurchaseCommon Stock | 22,000 | $0.72 | $15,752.00 |
DisclosureSEC source: 0001209191-18-049509 · doc4.xml · nonDerivative · entry 2 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 714,328 F1 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $0.6999 to $0.72 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F2 · ownership.nature: These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.